It means it cash almost born out now for second Q, Am I right? They have to issue more shares or get loan?
Its balance sheet looks ugly and run out of cash.
Any biotech stock has big potential loss before drug going into market, RCPT is long way from it.
Mark my word: This stock pump up without any solid news or FA support. it was just the manipulation.
Cancer treatment data is so great for a small company with 50 millions of CAP.
You can find a lot biotech stocks with several Billions CAP without any drug to market.
ICPT RCPT JUNO KITE etc